These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Goodwin GM; Green AR Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582 [TBL] [Abstract][Full Text] [Related]
24. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat. González MI; Albonetti E; Siddiqui A; Farabollini F; Wilson CA Pharmacol Biochem Behav; 1996 May; 54(1):195-203. PubMed ID: 8728558 [TBL] [Abstract][Full Text] [Related]
25. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs. Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288 [TBL] [Abstract][Full Text] [Related]
26. Brain 5-HT1A receptor autoradiography and hypothermic responses in rats bred for differences in 8-OH-DPAT sensitivity. Knapp DJ; Overstreet DH; Crews FT Brain Res; 1998 Jan; 782(1-2):1-10. PubMed ID: 9519243 [TBL] [Abstract][Full Text] [Related]
27. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Burnet PW; Eastwood SL; Harrison PJ Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998 [TBL] [Abstract][Full Text] [Related]
28. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists. De Souza RJ; Goodwin GM; Green AR; Heal DJ Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344 [TBL] [Abstract][Full Text] [Related]
29. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine. Wieland S; Kreider MS; McGonigle P; Lucki I Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505 [TBL] [Abstract][Full Text] [Related]
30. Corticosterone modulation of somatodendritic 5-HT1A receptor function in mice. Man MS; Young AH; McAllister-Williams RH J Psychopharmacol; 2002 Sep; 16(3):245-52. PubMed ID: 12236633 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635. Khawaja X; Ennis C; Minchin MC Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968 [TBL] [Abstract][Full Text] [Related]
32. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Mendelson SD; McEwen BS Neuroendocrinology; 1992 Apr; 55(4):444-50. PubMed ID: 1533016 [TBL] [Abstract][Full Text] [Related]
33. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471 [TBL] [Abstract][Full Text] [Related]
34. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats. Krebs KM; Geyer MA Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists. Bagdy G; Sved AF; Murphy DL; Szemeredi K Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317 [TBL] [Abstract][Full Text] [Related]
36. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
37. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat. Bagdy G; Kalogeras KT Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526 [TBL] [Abstract][Full Text] [Related]
38. Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems. Uchitomi Y; Yamawaki S Psychopharmacology (Berl); 1993; 112(1):74-9. PubMed ID: 7871012 [TBL] [Abstract][Full Text] [Related]
39. Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat. Baudrie V; De Vry J; Broqua P; Schmidt B; Chaouloff F; Glaser T Eur J Pharmacol; 1993 Feb; 231(3):395-406. PubMed ID: 8095465 [TBL] [Abstract][Full Text] [Related]
40. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies. Gur E; Dremencov E; Lerer B; Newman ME Eur J Pharmacol; 2001 Jan; 411(1-2):115-122. PubMed ID: 11137865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]